Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -281,584 | -235,259 | -245,192 | -289,403 | -271,393 |
| Depreciation Amortization | 4,402 | -847 | 2,427 | 2,422 | 1,917 |
| Accounts receivable | -12,466 | -9,691 | -8,747 | -11,440 | -5,903 |
| Accounts payable and accrued liabilities | 1,271 | 4,055 | -5,619 | 4,874 | 2,240 |
| Other Working Capital | 11,036 | 3,705 | -8,197 | -6,312 | 6,394 |
| Other Operating Activity | 141,175 | 86,907 | 97,858 | 82,102 | 58,337 |
| Operating Cash Flow | $-136,166 | $-151,130 | $-167,470 | $-217,757 | $-208,408 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 200,096 | -164,707 | -66,236 | 93,285 | -252,418 |
| PPE Investments | -7,587 | -1,129 | -2,104 | -812 | -1,506 |
| Purchase Of Investment | N/A | N/A | -3,149 | 0 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -8,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -8,000 |
| Investing Cash Flow | $192,509 | $-165,836 | $-71,489 | $92,473 | $-261,924 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,996 | 371,847 | 306,647 | 31,188 | 519,492 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 14,320 |
| Financing Cash Flow | $80,996 | $371,847 | $306,647 | $31,188 | $533,812 |
| Exchange Rate Effect | -8 | 2 | 3 | -6 | 2 |
| Beginning Cash Position | 194,467 | 139,584 | 71,893 | 165,995 | 102,513 |
| End Cash Position | 331,798 | 194,467 | 139,584 | 71,893 | 165,995 |
| Net Cash Flow | $137,331 | $54,883 | $67,691 | $-94,102 | $63,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,166 | -151,130 | -167,470 | -217,757 | -208,408 |
| Capital Expenditure | -7,587 | -1,129 | -2,104 | -812 | -1,506 |
| Free Cash Flow | -143,753 | -152,259 | -169,574 | -218,569 | -209,914 |